Etoricoxib in Acute Soft Tissue Rheumatism Affecting the Shoulder

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2009
The purpose of this study is to evaluate the efficacy and safety two oral doses of etoricoxib (60 mg and 90 mg) daily in acute soft tissue rheumatism affecting the shoulder.
Epistemonikos ID: 2daffc2a329ca346f6bbb6a22f94126adb1e42d8
First added on: May 05, 2024